Ep. #48 - David Wolf, Do Regulatory Restrictions Hinder or Help Innovation in the Fertility Field?

Inside Reproductive Health Podcast

English - November 25, 2019 10:00 - 43 minutes - 59.5 MB - ★★★★★ - 29 ratings
Society & Culture Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep. #47 - Geographical Differences in 3rd Party Reproduction, An Interview with Liz Ellwood

Next Episode: Ep. #49 - Do the Psychological Effects of Infertility Dictate Patient Decisions? An Interview with Amira Posner

Consolidation, IPO, publicly-owned...all words that weren’t a part of the fertility world vocabulary 10 years ago. Now, they are becoming more and more common, which can be both exciting and nerve-wracking to entrepreneurs in the field. On this episode of Inside Reproductive Health, Griffin Jones, founder of Fertility Bridge, talks to David Wolf, President and CEO of Hamilton Thorne. They discuss the implications of consolidation coming into the fertility world as well as the pros and cons of both publicly- and privately-owned clinics and suppliers.